US Advisory Panel Endorses Moderna's COVID-19 Booster Shot for Older, At-Risk Persons

Back in September, the US Food and Drug Administration authorized a Pfizer-BioNTech COVID-19 vaccine booster shot for those aged 65 years old and up, and others at risk of severe illness from COVID-19.